Beurs gesloten -
Nasdaq
22:30:01 17-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
0,6589
USD
|
+1,34%
|
|
-4,03%
|
-21,56%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
39,24
|
170,9
|
71,25
|
26,24
|
41,96
|
34,13
|
-
|
-
|
Bedrijfswaarde
1 |
39,24
|
170,9
|
71,25
|
26,24
|
41,96
|
34,13
|
34,13
|
34,13
|
K/w-verhouding
|
-7,51
x
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
-
|
164
x
|
76,6
x
|
15,7
x
|
7,44
x
|
2,01
x
|
1,08
x
|
0,57
x
|
Bedrijfswaarde/omzet
|
-
|
164
x
|
76,6
x
|
15,7
x
|
7,44
x
|
2,01
x
|
1,08
x
|
0,57
x
|
Bedrijfswaarde/EBITDA
|
-
|
-
|
-
|
-
|
-1,91
x
|
-1,93
x
|
-2,54
x
|
-171
x
|
Bedrijfswaarde/FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Aantal aandelen (in duizenden)
|
25.754
|
35.575
|
41.164
|
41.216
|
50.550
|
50.659
|
-
|
-
|
Referentieprijs
2 |
5,256
|
15,44
|
5,375
|
2,235
|
2,998
|
2,491
|
2,491
|
2,491
|
Datum van publicatie
|
4/03/20
|
3/03/21
|
10/03/22
|
9/03/23
|
7/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
-
|
1,04
|
0,93
|
1,675
|
5,64
|
17
|
31,5
|
60
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-22,02
|
-17,72
|
-13,42
|
-0,2
|
Bedrijfsresultaat (EBIT)
1 |
-
|
-24,81
|
-30,95
|
-26,94
|
-26,51
|
-22,92
|
-19,22
|
-7,4
|
Operationele Marge
|
-
|
-2.385,96%
|
-3.328,28%
|
-1.608,42%
|
-470%
|
-134,85%
|
-61,03%
|
-12,33%
|
Resultaat voor belastingen (EBT)
1 |
-
|
-26,17
|
-30,43
|
-29,75
|
-25,99
|
-22,92
|
-19,22
|
-7,4
|
Nettowinst (verlies)
1 |
-18,11
|
-23,37
|
-27,79
|
-26,64
|
-23,88
|
-20,92
|
-17,22
|
-5,4
|
Nettomarge
|
-
|
-2.247,5%
|
-2.988,49%
|
-1.590,33%
|
-423,39%
|
-123,09%
|
-54,68%
|
-9%
|
WPA
|
-0,7000
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF-marge
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
4/03/20
|
3/03/21
|
10/03/22
|
9/03/23
|
7/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
0,151
|
0,311
|
0,237
|
0,312
|
0,466
|
0,66
|
0,641
|
0,654
|
3,767
|
0,578
|
3,5
|
2,5
|
8
|
3
|
2,5
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-5,737
|
-6,453
|
-2,977
|
-6,852
|
-3,55
|
-5,325
|
-3,5
|
-5,35
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-8,556
|
-8,692
|
-8,055
|
-8,007
|
-7,097
|
-3,782
|
-6,796
|
-7,901
|
-4,183
|
-7,628
|
-4,85
|
-6,625
|
-4,8
|
-6,65
|
-
|
Operationele Marge
|
-5.666,23%
|
-2.794,86%
|
-3.398,73%
|
-2.566,35%
|
-1.522,96%
|
-573,03%
|
-1.060,22%
|
-1.208,1%
|
-111,04%
|
-1.319,72%
|
-138,57%
|
-265%
|
-60%
|
-221,67%
|
-
|
Resultaat voor belastingen (EBT)
1 |
-8,335
|
-8,09
|
-9,104
|
-9,716
|
-7,158
|
-3,776
|
-7,026
|
-7,757
|
-3,863
|
-7,341
|
-4,85
|
-6,625
|
-4,8
|
-6,65
|
-
|
Nettowinst (verlies)
1 |
-7,61
|
-7,371
|
-9,106
|
-8,821
|
-6,544
|
-2,998
|
-6,271
|
-7,023
|
-3,984
|
-6,601
|
-4,35
|
-6,125
|
-4,3
|
-6,15
|
-
|
Nettomarge
|
-5.039,74%
|
-2.370,1%
|
-3.842,19%
|
-2.827,24%
|
-1.404,29%
|
-454,24%
|
-978,32%
|
-1.073,85%
|
-105,76%
|
-1.142,04%
|
-124,29%
|
-245%
|
-53,75%
|
-205%
|
-
|
WPA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
17/11/21
|
10/03/22
|
26/05/22
|
31/08/22
|
17/11/22
|
9/03/23
|
18/05/23
|
17/08/23
|
15/11/23
|
7/03/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
1,17
|
-
|
-
|
-
|
-
|
Capex/omzet
|
-
|
-
|
-
|
69,91%
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
4/03/20
|
3/03/21
|
10/03/22
|
9/03/23
|
7/03/24
|
-
|
-
|
-
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -0,09% | 42,12 mld. | | +49,62% | 42,05 mld. | | -4,96% | 29,18 mld. | | +11,18% | 26,02 mld. | | -21,95% | 18,9 mld. | | +8,61% | 13,21 mld. | | +24,73% | 12,17 mld. | | +28,31% | 12,16 mld. | | -6,26% | 11,42 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|